Coronavirus Update: Trump Tests Positive, US Pause Remains On AstraZeneca Vaccine
Plus: Gilead Takes Over Remdesivir Supply
Meanwhile, seven former US FDA commissioners issue joint plea for trust in the scientific integrity of the agency.
You may also be interested in...
The head of global vaccine and plasma segments, bioprocessing, at German multinational Merck discusses key aspects around evolving vaccine manufacturing to improve the efficiency and speed of response during a pandemic. Pre-existing manufacturing platforms, the executive says, could compress process development work and fast-track scale-up.
NIH study of monoclonal antibody therapy in combination with Gilead's remdesivir paused for safety reasons.
It will be several days at least before more information is available about the unexpected illness in J&J's Phase III COVID-19 vaccine trial, the firm said during its third quarter financial call.